ORIGINAL ARTICLE
EVALUATION OF THE ØREBLUE® METHOD IN THE TREATMENT OF TINNITUS AND HYPERACUSIS: RESULTS OF A MONOCENTRIC OBSERVATIONAL EFFECTIVENESS STUDY IN 74 PATIENTS
 
 
 
More details
Hide details
1
MayFair Developments, Hearing Institute of Resources, France
 
2
private practice, ORL, France
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
 
 
Publication date: 2021-08-31
 
 
Corresponding author
Natacha CHETRITT-BONNEYRAT   

MayFair Developments, Hearing Institute of Resources, 18 Quai Sénac de Meilhan, 17000, LA ROCHELLE, France
 
 
J Hear Sci 2021;11(2):44-51
 
KEYWORDS
TOPICS
ABSTRACT
Background:
Øreblue® is a new treatment method for tinnitus and hyperacusis combining auditive rehabilitation and psychological therapy. The present monocentric observational retrospective study was to assess patient’s judgements of its effectiveness.

Material and methods:
From January 2011 to June 2015, 74 consecutive healthy patients (male/female, 51/23; median age, 51.5 years) with chronic tinnitus (without hyperacusis, 32) or hyperacusis (with tinnitus, 42) were treated according to priority at the Hearing Institute of Resources (La Rochelle, France). They were asked to rank their discomfort, quality of life, and sleep quality before and 1 month after treatment using 10-point scales ranging from 0 (no discomfort, poor quality of life, or poor sleep quality) to 10 (unbearable discomfort, best quality of life, or best sleep quality) and their global impression of change on a 10-point scale ranging from 0% (not improved) to 100% (fully improved). These data which were reported in patient medical files were retrospectively analysed in 2018.

Results:
Discomfort, which was severe at inclusion (8.9±0.8), drastically decreased after treatment (change: 8.5±1.3). Quality of life and sleep improved (from 2.2±1.4 and 2.0±1.9 to 8.3±1.4 and 4.9±2.1, respectively). 81.3% of the patients with tinnitus and 100% of patients with hyperacusis claimed to be fully improved. No adverse events were reported during the study.

Conclusions:
The Øreblue® method was effective on discomfort related to tinnitus or hyperacusis; it greatly improved quality of life and sleep. Further studies, especially multicentric or randomised, possibly with imaging and long-term follow-up, should be performed to strengthen these encouraging findings.

REFERENCES (20)
1.
Auerbach BD. Physiological mechanisms of hyperacusis: an update. ENT & Audiology News, 2019; 27(6).
 
2.
Cremer G. Retrospective study of the ØREBLUE® method on a prospectively formed cohort, 2019. https://hearing-institute-of-r....
 
3.
Baguley DM. Hyperacusis. J Roy Soc Med, 2003; 96(12): 582-5.
 
4.
Hall DA, Fackrell K, Li AB, et al. A narrative synthesis of research evidence for tinnitus-related complaints as reported by patients and their significant others. Health Qual Life Outcomes, 2018; 16(1): 61.
 
5.
Aazh H, Moore BCJ. Factors associated with depression in patients with tinnitus and hyperacusis. Am J Audiol, 2017; 26(4): 562–9.
 
6.
Baguley DM, Hoare DJ. Hyperacusis: major research questions. HNO, 2018; 66(5): 358–63.
 
7.
Hall DA, Hibbert A, Smith H, et al. One size does not fit all: developing common standards for outcomes in early-phase clinical trials of sound-, psychology-, and pharmacology-based interventions for chronic subjective tinnitus in adults. Trends Hear, 2019; 23: 2331216518824827.
 
8.
Aazh H, Moore BC, Lammaing K, Cropley M. Tinnitus and hyperacusis therapy in a UK National Health Service audiology department: patients’ evaluations of the effectiveness of treatments. Int J Audiol, 2016; 55(9): 514-22.
 
9.
Cima RFF, Mazurek B, Haider H, et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO, 2019; 67(Suppl 1): 10–42.
 
10.
Fioretti A, Eibenstein A, Fusetti M. New trends in tinnitus management. Open Neurol J, 2011; 5: 12–7.
 
11.
Falkenberg ES, Wie OB. Anxiety and depression in tinnitus patients: 5-year follow-up assessment after completion of habituation therapy. Int J Otolaryngol, 2012; 2012: 375460.
 
12.
Stracke H, Okamoto H, Pantev C. Customized notched music training reduces tinnitus loudness. Commun Integr Biol, 2010; 3(3): 274–7.
 
13.
Argstatter H, Plinkert P, Bolay HV. [Music therapy for tinnitus patients: an interdisciplinary pilot study of the Heidelberg Model]. HNO, 2007; 55(5): 375–83 [in German].
 
14.
McCormack A, Edmondson-Jones M, Somerset S, Hall D. A systematic review of the reporting of tinnitus prevalence and severity. Hear Res, 2016; 337: 70–9.
 
15.
Nicolas-Puel C, Akbaraly T, et al. Characteristics of tinnitus in a population of 555 patients: specificities of tinnitus induced by noise trauma. Int Tinnitus J, 2006; 12(1): 64–70.
 
16.
Anari M, Axelsson A, Eliasson A, Magnusson L. Hypersensitivity to sound-questionnaire data, audiometry and classification. Scand Audiol, 1999; 28(4): 219–30.
 
17.
Stohler NA, Reinau D, Jick SS, Bodmer D, Meier CR. A study on the epidemiology of tinnitus in the United Kingdom. Clin Epidemiol, 2019; 11: 855–71.
 
18.
Ghulyan-Bédikian V, Paolino M, Giorgetti-D’Esclercs F, Paolino F. Propriétés psychométriques d’une version française du Tinnitus Handicap Inventory. Encephale, 2010; 36(5): 390–6 [in French].
 
19.
Flores M, Glusman G, Brogaard K, Price ND, Hood L. P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med, 2013; 10(6): 565–76.
 
20.
Scheen AJ, Giet D. Médecine personnalisée: tout bénéfice pour le patient, mais nouveau challenge pour la relation médecin-malade. Rev Med Liege, 2015; 70(5-6): 247–50 [in French].
 
Journals System - logo
Scroll to top